Results 81 to 90 of about 60,212 (254)
A STUDY OF THE LEUKOCYTOSIS PRODUCED IN MAN BY ARTIFICIAL FEVER 1 [PDF]
Peter Cohen, Stafford L. Warren
openalex +1 more source
Infección intrahospitalaria en pacientes con cáncer Nosocomial infection in patients with cancer
Se efectuó una investigación descriptiva y transversal de todos los pacientes con cáncer que presentaron alguna infección intrahospitalaria en el Hospital Oncológico Provincial "Conrado Benítez" de Santiago de Cuba, desde enero hasta septiembre del 2009,
María Cristina Céspedes Quevedo+4 more
doaj
LEUKOCYTOSIS FOLLOWING THE INTRAMUSCULAR INJECTION OF LIVER EXTRACT [PDF]
John H. Powers+2 more
openalex +1 more source
Las urgencias que pueden surgir durante la evolución de las enfermedades hematológicas son diversas, tanto por el comportamiento de la enfermedad de base como por el momento en que se presentan.
Juan Carlos Jaime-Fagundo+4 more
doaj
A case report of a young female with plasma cells leukemia
Plasma cell leukemia (PCL) is a rare and aggressive variant of plasma cell dyscrasias that can occur either de novo (primary) or as a leukemic transformation of end-stage multiple myeloma (MM).
Nawshirwan Gafoor Rashid+1 more
doaj +1 more source
Leukocytosis in Inflammatory Disease of the Adnexa [PDF]
NULL AUTHOR_ID
openalex +1 more source
Defining the Limits of Postpartum Leukocytosis: A Retrospective Cohort Study
There are established reference ranges for many laboratory values during pregnancy. Fewer studies exist regarding the expected white blood cell (WBC) count after delivery.
Lindsay A. Hartup+4 more
doaj +1 more source
Environmental modulators of vascular physiology and inflammation
Abstract Environmental factors play a crucial role in modulating vascular inflammation, contributing significantly to the development of atherosclerosis and cardiovascular disease. This review synthesizes current evidence on how various environmental exposures influence vascular function and inflammation, with a focus on pollutants such as particulate ...
Anusha N. Seneviratne+3 more
wiley +1 more source
BackgroundLorlatinib is a new generation ALK kinase inhibitor. We describe a 52-year-old patient with ALK-positive advanced lung adenocarcinoma who achieved remission after multi-line therapy combined with paraneoplastic leukemoid reaction treated with ...
Ruiqi Niu+5 more
doaj +1 more source
Abstract Hepatocellular carcinoma (HCC) is the sixth most common malignancy and the third leading cause of cancer‐related death worldwide. Contemporary advances in systemic and locoregional therapies have led to changes in peer‐reviewed guidelines regarding systemic therapy as well as the possibility of downstaging disease that may enable some patients
Dimitrios Moris+12 more
wiley +1 more source